217 related articles for article (PubMed ID: 8040612)
1. In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions.
Schwarz A; Grabbe S; Riemann H; Aragane Y; Simon M; Manon S; Andrade S; Luger TA; Zlotnik A; Schwarz T
J Invest Dermatol; 1994 Aug; 103(2):211-6. PubMed ID: 8040612
[TBL] [Abstract][Full Text] [Related]
2. Neutralization of IL-12 in vivo prevents induction of contact hypersensitivity and induces hapten-specific tolerance.
Riemann H; Schwarz A; Grabbe S; Aragane Y; Luger TA; Wysocka M; Kubin M; Trinchieri G; Schwarz T
J Immunol; 1996 Mar; 156(5):1799-803. PubMed ID: 8596029
[TBL] [Abstract][Full Text] [Related]
3. Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity.
Schwarz A; Maeda A; Wild MK; Kernebeck K; Gross N; Aragane Y; Beissert S; Vestweber D; Schwarz T
J Immunol; 2004 Jan; 172(2):1036-43. PubMed ID: 14707077
[TBL] [Abstract][Full Text] [Related]
4. Diversion of CD4+ T cell development from regulatory T helper to effector T helper cells alters the contact hypersensitivity response.
DiIulio NA; Xu H; Fairchild RL
Eur J Immunol; 1996 Nov; 26(11):2606-12. PubMed ID: 8921946
[TBL] [Abstract][Full Text] [Related]
5. The role of IL-4, IL-10, and TNF-alpha in the immune suppression induced by ultraviolet radiation.
Rivas JM; Ullrich SE
J Leukoc Biol; 1994 Dec; 56(6):769-75. PubMed ID: 7996051
[TBL] [Abstract][Full Text] [Related]
6. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells.
Xu H; DiIulio NA; Fairchild RL
J Exp Med; 1996 Mar; 183(3):1001-12. PubMed ID: 8642241
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 receptor antagonist suppresses contact hypersensitivity.
Kondo S; Pastore S; Fujisawa H; Shivji GM; McKenzie RC; Dinarello CA; Sauder DN
J Invest Dermatol; 1995 Sep; 105(3):334-8. PubMed ID: 7665908
[TBL] [Abstract][Full Text] [Related]
8. Pentoxifylline suppresses irritant and contact hypersensitivity reactions.
Schwarz A; Krone C; Trautinger F; Aragane Y; Neuner P; Luger TA; Schwarz T
J Invest Dermatol; 1993 Oct; 101(4):549-52. PubMed ID: 8409522
[TBL] [Abstract][Full Text] [Related]
9. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity.
Grabbe S; Steinbrink K; Steinert M; Luger TA; Schwarz T
J Immunol; 1995 Nov; 155(9):4207-17. PubMed ID: 7594576
[TBL] [Abstract][Full Text] [Related]
10. Topical glucocorticoids application induced an augmentation in the expression of IL-1alpha while inhibiting the expression of IL-10 in the epidermis in murine contact hypersensitivity.
Igawa K; Yokozeki H; Miyazaki Y; Minatohara K; Satoh T; Katayama I; Nishioka K
Clin Exp Allergy; 2001 Mar; 31(3):485-94. PubMed ID: 11260162
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide.
Asahina A; Hosoi J; Beissert S; Stratigos A; Granstein RD
J Immunol; 1995 Apr; 154(7):3056-61. PubMed ID: 7897198
[TBL] [Abstract][Full Text] [Related]
12. Novel function of DUSP14/MKP6 (dual specific phosphatase 14) as a nonspecific regulatory molecule for delayed-type hypersensitivity.
Nakano Y
Br J Dermatol; 2007 May; 156(5):848-60. PubMed ID: 17263825
[TBL] [Abstract][Full Text] [Related]
13. Itraconazole suppresses an elicitation phase of a contact hypersensitivity reaction.
Ausaneya U; Kawada A; Aragane Y
J Invest Dermatol; 2006 May; 126(5):1028-35. PubMed ID: 16514416
[TBL] [Abstract][Full Text] [Related]
14. Contact hypersensitivity reactions to dinitrofluorobenzene mediated by monoclonal IgE anti-DNP antibodies.
Ray MC; Tharp MD; Sullivan TJ; Tigelaar RE
J Immunol; 1983 Sep; 131(3):1096-102. PubMed ID: 6193174
[TBL] [Abstract][Full Text] [Related]
15. Enhanced contact hypersensitivity by delayed T-helper 2 response in BALB/c mice.
Hayashi T; Hara S; Hasegawa K
Allergy Asthma Proc; 2009; 30(4):449-57. PubMed ID: 19772766
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide denervation alters both the elicitation and induction phases of contact hypersensitivity in mice.
Veronesi B; Williams WC; Smialowicz RJ; Sailstad DM; Doerfler D; Selgrade MJ
Toxicol Appl Pharmacol; 1998 Dec; 153(2):243-9. PubMed ID: 9878594
[TBL] [Abstract][Full Text] [Related]
17. Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity.
Yokozeki H; Ghoreishi M; Takagawa S; Takayama K; Satoh T; Katayama I; Takeda K; Akira S; Nishioka K
J Exp Med; 2000 Mar; 191(6):995-1004. PubMed ID: 10727461
[TBL] [Abstract][Full Text] [Related]
18. Blockade of CD40-CD40 ligand pathway induces tolerance in murine contact hypersensitivity.
Tang A; Judge TA; Turka LA
Eur J Immunol; 1997 Dec; 27(12):3143-50. PubMed ID: 9464799
[TBL] [Abstract][Full Text] [Related]
19. Roxithromycin inhibits the effector phase of delayed-type hypersensitivity.
Liu K; Xu Q
Int Immunopharmacol; 2008 Jan; 8(1):126-31. PubMed ID: 18068108
[TBL] [Abstract][Full Text] [Related]
20. Induction of hapten-specific tolerance by interleukin 10 in vivo.
Enk AH; Saloga J; Becker D; Mohamadzadeh M; Knop J
J Exp Med; 1994 Apr; 179(4):1397-402. PubMed ID: 8145053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
